DCP
DSM Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-932,595
| Closed | -$127M | – | 43 |
|
|
2024
Q4 | $127M | Sell |
932,595
-11,559
| -1% | -$1.58M | 1.97% | 17 |
|
|
2024
Q3 | $109M | Sell |
944,154
-53,630
| -5% | -$6.18M | 1.66% | 18 |
|
|
2024
Q2 | $137M | Sell |
997,784
-138,218
| -12% | -$19M | 1.99% | 17 |
|
|
2024
Q1 | $157M | Sell |
1,136,002
-86,007
| -7% | -$11.9M | 2.14% | 16 |
|
|
2023
Q4 | $161M | Sell |
1,222,009
-2,008
| -0.2% | -$265K | 2.46% | 15 |
|
|
2023
Q3 | $138M | Buy |
1,224,017
+163,747
| +15% | +$18.4M | 2.32% | 14 |
|
|
2023
Q2 | $100M | Sell |
1,060,270
-199,261
| -16% | -$18.8M | 1.62% | 24 |
|
|
2023
Q1 | $127M | Sell |
1,259,531
-73,172
| -5% | -$7.41M | 2.09% | 23 |
|
|
2022
Q4 | $159M | Buy |
1,332,703
+10,501
| +0.8% | +$1.25M | 2.65% | 13 |
|
|
2022
Q3 | $140M | Sell |
1,322,202
-9,258
| -0.7% | -$983K | 2.38% | 15 |
|
|
2022
Q2 | $130M | Sell |
1,331,460
-19,871
| -1% | -$1.94M | 2.18% | 14 |
|
|
2022
Q1 | $127M | Sell |
1,351,331
-56,866
| -4% | -$5.33M | 1.69% | 23 |
|
|
2021
Q4 | $120M | Sell |
1,408,197
-104,913
| -7% | -$8.94M | 1.26% | 26 |
|
|
2021
Q3 | $145M | Sell |
1,513,110
-22,374
| -1% | -$2.15M | 1.51% | 21 |
|
|
2021
Q2 | $149M | Buy |
1,535,484
+186,977
| +14% | +$18.2M | 1.44% | 25 |
|
|
2021
Q1 | $131M | Buy |
1,348,507
+232,127
| +21% | +$22.6M | 1.4% | 23 |
|
|
2020
Q4 | $107M | Buy |
1,116,380
+279,614
| +33% | +$26.8M | 1.15% | 25 |
|
|
2020
Q3 | $80.5M | Sell |
836,766
-28,848
| -3% | -$2.77M | 0.89% | 24 |
|
|
2020
Q2 | $106M | Buy |
865,614
+5,561
| +0.6% | +$678K | 1.26% | 21 |
|
|
2020
Q1 | $74.4M | Buy |
860,053
+189,504
| +28% | +$16.4M | 1.13% | 24 |
|
|
2019
Q4 | $72.1M | Buy |
670,549
+19,336
| +3% | +$2.08M | 0.95% | 29 |
|
|
2019
Q3 | $58.7M | Sell |
651,213
-9,311
| -1% | -$839K | 0.9% | 28 |
|
|
2019
Q2 | $55.8M | Sell |
660,524
-35,658
| -5% | -$3.01M | 0.81% | 28 |
|
|
2019
Q1 | $61.3M | Buy |
+696,182
| New | +$61.3M | 0.9% | 29 |
|